Back to Search
Start Over
Venetoclax and ibrutinib for patients with relapsed/refractory chronic lymphocytic leukemia
- Source :
- Blood, 137(8), 1117-1120. AMER SOC HEMATOLOGY, Niemann, C U, Levin, M-D, Dubois, J, Kersting, S, Enggaard, L, Veldhuis, G J, Mous, R, Mellink, C H M, Dobber, J A, Poulsen, C B, Frederiksen, H, Janssens, A, Schjødt, I, Dompeling, E C, Ranti, J, Mattsson, M, Bellido, M, Tran, H T T, Nasserinejad, K & Kater, A P 2021, ' Venetoclax and Ibrutinib for Patients with Relapsed/Refractory Chronic Lymphocytic Leukemia ', Blood, vol. 137, no. 8, pp. 1117-1120 . https://doi.org/10.1182/blood.2020008608, Blood, 137(8), 1117-1120. American Society of Hematology, Niemann, C U, Levin, M-D, Dubois, J, Kersting, S, Enggaard, L, Veldhuis, G J, Mous, R, Mellink, C H M, Dobber, J A, Poulsen, C B, Frederiksen, H, Janssens, A, Schjødt, I, Dompeling, E C, Ranti, J, Mattsson, M, Bellido, M, Tran, H T T, Nasserinejad, K & Kater, A P 2021, ' Venetoclax and ibrutinib for patients with relapsed/refractory chronic lymphocytic leukemia ', Blood, vol. 137, no. 8, pp. 1117-1120 . https://doi.org/10.1182/blood.2020008608
- Publication Year :
- 2021
-
Abstract
- ispartof: BLOOD vol:137 issue:8 pages:1117-1120 ispartof: location:United States status: published
- Subjects :
- Oncology
medicine.medical_specialty
Science & Technology
Venetoclax
business.industry
Chronic lymphocytic leukemia
Immunology
Cell Biology
Hematology
medicine.disease
Biochemistry
1ST-LINE TREATMENT
chemistry.chemical_compound
chemistry
Ibrutinib
Internal medicine
Relapsed refractory
medicine
RITUXIMAB
business
Life Sciences & Biomedicine
Subjects
Details
- Language :
- English
- ISSN :
- 00064971
- Volume :
- 137
- Issue :
- 8
- Database :
- OpenAIRE
- Journal :
- Blood
- Accession number :
- edsair.doi.dedup.....fdc9ad8a3176dac8f8c391574fbbaa55
- Full Text :
- https://doi.org/10.1182/blood.2020008608